Literature DB >> 16893915

Peptide and protein profiles in serum and follicular fluid of women undergoing IVF.

Florian J Schweigert1, Beate Gericke, Wiebke Wolfram, Udo Kaisers, Joachim W Dudenhausen.   

Abstract

BACKGROUND: Proteins and peptides in human follicular fluid originate from plasma or are produced by follicular structures. Compositional changes reflect oocyte maturation and can be used as diagnostic markers. The aim of the study was to determine protein and peptide profiles in paired serum and follicular fluid samples from women undergoing IVF.
METHODS: Surface-enhanced laser desorption and ionization-time of flight-mass spectrometry (SELDI-TOF-MS) was used to obtain characteristic protein pattern.
RESULTS: One hundred and eighty-six individual MS signals were obtained from a combination of enrichment on strong anion exchanger (110), weak cation exchanger (52) and normal phase surfaces (24). On the basis of molecular masses, isoelectric points and immunoreactivety, four signals were identified as haptoglobin (alpha(1)- and alpha(2)-chain), haptoglobin 1 and transthyretin (TTR). Immunological and MS characteristics of the TTR : retinol-binding protein (RBP) transport complex revealed no microheterogeneity differences between serum and follicular fluid. Discriminatory patterns arising from decision-tree-based classification and regression analysis distinguished between serum and follicular fluid with a sensitivity and specificity of 100%.
CONCLUSIONS: Quantitative and qualitative differences indicate selective transport processes rather than mere filtration across the blood-follicle barrier. Identified proteins as well as characteristic peptide and/or protein signatures might emerge as potential candidates for diagnostic markers of follicle and/or oocyte maturation and thus oocyte quality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16893915     DOI: 10.1093/humrep/del257

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  25 in total

1.  Perfluoroalkyl and polyfluoroalkyl substances (PFAS) and their effects on the ovary.

Authors:  Ning Ding; Siobán D Harlow; John F Randolph; Rita Loch-Caruso; Sung Kyun Park
Journal:  Hum Reprod Update       Date:  2020-09-01       Impact factor: 15.610

Review 2.  Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.

Authors:  Muriel De Bock; Dominique de Seny; Marie-Alice Meuwis; Jean-Paul Chapelle; Edouard Louis; Michel Malaise; Marie-Paule Merville; Marianne Fillet
Journal:  J Biomed Biotechnol       Date:  2009-12-06

Review 3.  The Use of Proteomics in Assisted Reproduction.

Authors:  Ioanna Kosteria; Athanasios K Anagnostopoulos; Christina Kanaka-Gantenbein; George P Chrousos; George T Tsangaris
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

4.  Analysis of follicular fluid retinoids in women undergoing in vitro fertilization: retinoic acid influences embryo quality and is reduced in women with endometriosis.

Authors:  Samuel A Pauli; Donna R Session; Weirong Shang; Kirk Easley; Friedrich Wieser; Robert N Taylor; Keely Pierzchalski; Joseph L Napoli; Maureen A Kane; Neil Sidell
Journal:  Reprod Sci       Date:  2013-02-20       Impact factor: 3.060

5.  Effects of EG-VEGF, VEGF and TGF-β1 on pregnancy outcome in patients undergoing IVF-ET treatment.

Authors:  Min-zhi Gao; Xiao-ming Zhao; Yi Lin; Zhao-gui Sun; Hui-qin Zhang
Journal:  J Assist Reprod Genet       Date:  2012-07-31       Impact factor: 3.412

6.  A proteomic analysis of IVF follicular fluid in women <or=32 years old.

Authors:  Stephanie J Estes; Bin Ye; Weiliang Qiu; Daniel Cramer; Mark D Hornstein; Stacey A Missmer
Journal:  Fertil Steril       Date:  2008-11-05       Impact factor: 7.329

7.  Steroid hormones content and proteomic analysis of canine follicular fluid during the preovulatory period.

Authors:  Somayyeh Fahiminiya; Karine Reynaud; Valérie Labas; Séverine Batard; Sylvie Chastant-Maillard; Nadine Gérard
Journal:  Reprod Biol Endocrinol       Date:  2010-11-01       Impact factor: 5.211

8.  The blood-follicle barrier (BFB) in disease and in ovarian function.

Authors:  Michelle K Y Siu; C Yan Cheng
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

9.  Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model.

Authors:  Satyan S Kalkunte; Stefan Neubeck; Wendy E Norris; Shi-Bin Cheng; Stefan Kostadinov; Dang Vu Hoang; Aftab Ahmed; Ferdinand von Eggeling; Zahir Shaikh; James Padbury; Goran Berg; Anders Olofsson; Udo R Markert; Surendra Sharma
Journal:  Am J Pathol       Date:  2013-09-10       Impact factor: 4.307

10.  Single AAV-mediated CRISPR-Nme2Cas9 efficiently reduces mutant hTTR expression in a transgenic mouse model of transthyretin amyloidosis.

Authors:  Jinkun Wen; Tianqi Cao; Jinni Wu; Yuxi Chen; Shengyao Zhi; Yanming Huang; Peilin Zhen; Guanglan Wu; Lars Aagaard; Jianxin Zhong; Puping Liang; Junjiu Huang
Journal:  Mol Ther       Date:  2021-05-14       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.